Since the mechanisms of hypoxia-induced chemoresistance in HCC have not been fully elucidated, we conducted the following study to examine the roles of PTPN14, YAP and NPM1 in generation of resistance to the chemotherapeutic agent sorafenib. The gene discussed is NPM1; the disease is hepatocellular carcinoma.